Evidence map›Paper›PMID 41148641›Full record

ArticleInfectious disease reports2025

The Neutrophil/Lymphocyte Ratio Was Identified as a Marker of Severe Influenza During the 2024-2025 Outbreak in France.

Matteo Vassallo, Marion Derollez, Marc-Hadrien Veaute, Nicolas Clement, Roxane Fabre, Laurene Lotte, Yanis Kouchit, Sabrina Manni, Ursula Moracchini, Elea Blanchouin and 8 more

Abstract read
In one paragraph

Article in Infectious disease reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Matteo VassalloDepartment of Internal Medicine Infectious Diseases, Cannes Hospital, 06400 Cannes, France.
Marion DerollezDepartment of Internal Medicine Infectious Diseases, Cannes Hospital, 06400 Cannes, France.
Marc-Hadrien VeauteDepartment of Internal Medicine Infectious Diseases, Cannes Hospital, 06400 Cannes, France.
Nicolas ClementIntensive Care Unit, Cannes Hospital, 06400 Cannes, France.ORCID 0000-0002-9851-2666
Roxane FabrePublic Health Department, UR2CA-RESPECT, 06000 Nice, France.ORCID 0000-0001-5670-1322
Laurene LotteMultipurpose Laboratory, Bacteriology and Virology Unit, Cannes Hospital, 06400 Cannes, France.
Yanis KouchitIntensive Care Unit, Cannes Hospital, 06400 Cannes, France.
Sabrina ManniDepartment of Internal Medicine Infectious Diseases, Cannes Hospital, 06400 Cannes, France.
Ursula MoracchiniDepartment of Internal Medicine Infectious Diseases, Cannes Hospital, 06400 Cannes, France.
Elea BlanchouinDepartment of Internal Medicine Infectious Diseases, Cannes Hospital, 06400 Cannes, France.
Julie BetterDepartment of Internal Medicine Infectious Diseases, Cannes Hospital, 06400 Cannes, France.
Ludivine RerolleDepartment of Internal Medicine Infectious Diseases, Cannes Hospital, 06400 Cannes, France.
Raphael ChambonIntensive Care Unit, Cannes Hospital, 06400 Cannes, France.ORCID 0000-0001-6805-1267
Pierre Alfonsi BertrandIntensive Care Unit, Cannes Hospital, 06400 Cannes, France.
Sarah BaccialoneIntensive Care Unit, Cannes Hospital, 06400 Cannes, France.
Jerome LemoineIntensive Care Unit, Cannes Hospital, 06400 Cannes, France.ORCID 0009-0000-0774-9039
Audrey SindtMultipurpose Laboratory, Bacteriology and Virology Unit, Cannes Hospital, 06400 Cannes, France.
Pierre-Marie BertrandIntensive Care Unit, Cannes Hospital, 06400 Cannes, France.ORCID 0000-0002-2285-5638

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesInfluenza continues to cause high morbidity and mortality rates worldwide, inflicting a major burden on the public health system. There is little data available on the 2024-2025 seasonal outbreak. Moreover, biomarkers for rapidly identifying subjects at higher risk for severe forms are needed.

methodsWe retrospectively collected hospitalization data for influenza in Cannes, France, during the 2024-2025 seasonal outbreak. Severe forms were defined as cases either requiring admission to the Intensive Care Unit (ICU) or resulting in death. They were compared to uncomplicated forms. Main demographic, clinical, radiological, and laboratory characteristics were collected for each patient.

resultsFrom October 2024 to May 2025, 59 patients were admitted to either the Infectious Diseases Department or the ICU (56% male, age 72 years, 27% vaccinated, influenza type A 93%, symptom duration 3.5 days prior to hospitalization, 31% admissions to ICU, 14% deaths). Vaccination status did not differ between severe and uncomplicated forms. In the univariate analysis, severe forms had higher neutrophil/lymphocyte and platelet/lymphocyte ratios upon admission and included more cases of acute hepatitis, pneumonia, and oseltamivir use than uncomplicated forms. A neutrophil/lymphocyte ratio > 15 was independently associated with severity (OR

conclusionsThe N/L ratio was an easy-to-perform predictive marker for influenza severity during the 2024-2025 seasonal outbreak, warranting further prospective studies.

Indexed as

hospitalizationinfluenzaneutrophil/lymphocyte ratioseverity

Identifiers

PMID41148641
PMCPMC12562332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.